Gilead’s 4-in-1 Stribild HIV Pill Wins U.S. FDA Approval

Gilead Sciences Inc., the world’s biggest maker of AIDS drugs, won U.S. approval to sell a pill for new HIV patients that combines four of the company’s drugs into one.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.